0
Skip to Content
ICCFOP
ICC Members
ICC Committees
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
ICCFOP
ICC Members
ICC Committees
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
Folder: About Us
Back
ICC Members
ICC Committees
Contact
Folder: Treatment Guidelines
Back
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
Folder: Patients
Back
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Folder: Industry
Back
Clinical Trial Committee Chair
Folder: Healthcare Providers
Back
FOP Doctors and Specialists
Link to Clinical Trials
Folder: Media
Back
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info

COVID 19 Related Recommendations

June 19, 2023 – Coronavirus (COVID-19) Vaccine Recommendations

2022

May 10, 2022

  • Coronavirus (COVID 19) Recommendations - May 10, 2022

    • Spanish Recommendations - May 10, 2022

    • Korean Recommendations - May 10, 2022

    • Japanese Recommendations - May 10, 2022

January 10, 2022

  • January 10, 2022 – Coronavirus (COVID-19) Vaccine Recommendations

    • Portuguese Recommendations – January 10, 2022

    • Korean Recommendations – January 10, 2022

    • Spanish Recommendations – January 10, 2022

    • Japanese Recommendations – January 10, 2022

2021

  • March 18, 2021 – Coronavirus (COVID-19) Vaccine recommendations

    • Portuguese Recommendations March 18, 2021

    • French Recommendations March 18, 2021

    • Spanish Recommendations March 18, 2021

2020

  • December 30, 2020 – Updated Coronavirus (COVID-19) Precautions for FOP Families

  • July 17, 2020 – Updated Coronavirus (COVID-19) Precautions for FOP Families

  • March 27, 2020 – Updated Coronavirus (COVID-19) Precautions for FOP Families

  • March 18, 2020 – Revised Coronavirus (COVID-19) Precautions for FOP Families

  • March 16, 2020 – Coronavirus (COVID-19) Precautions for FOP Families

FOP and COVID-19 Webinar

 

View Webinar

Join our mailing list

Sign up to receive updates from us.

© 2025 The International Clinical Council (ICC) on Fibrodysplasia Ossificans Progressiva (FOP).